The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis
- PMID: 12766130
- DOI: 10.2337/diacare.26.6.1895
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis
Abstract
Objective: To examine by meta-analysis the relationship between cardiovascular autonomic neuropathy (CAN) and risk of mortality in individuals with diabetes.
Research design and methods: We searched Medline for English-language articles published from 1966 to 2001. Fifteen studies having a baseline assessment of cardiovascular autonomic function and mortality follow-up were identified. The analyses were stratified according to whether a single abnormality or two or more measures of cardiovascular autonomic function were used to define CAN. A global measure of association (i.e., relative risk) was generated for each group by pooling estimates across the studies using the Mantel-Haenszel procedure.
Results: CAN was significantly associated with subsequent mortality in both groups, although the magnitude of the association was stronger for those studies for which two or more measures were used to define CAN. The pooled relative risk for studies that defined CAN with the presence of two or more abnormalities was 3.45 (95% CI 2.66-4.47; P < 0.001) compared with 1.20 (1.02-1.41; P = 0.03) for studies that used one measure.
Conclusions: These results support an association between CAN and increased risk of mortality. The stronger association observed in studies defining CAN by the presence of two or more abnormalities may be due to more severe autonomic dysfunction in these subjects or a higher frequency of other comorbid complications that contributed to their higher mortality risk. Future studies should evaluate whether early identification of subjects with CAN can lead to a reduction in mortality.
Similar articles
-
Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study.Diabetes Care. 2001 Oct;24(10):1793-8. doi: 10.2337/diacare.24.10.1793. Diabetes Care. 2001. PMID: 11574444
-
Diabetic autonomic neuropathy.Diabetes Care. 2003 May;26(5):1553-79. doi: 10.2337/diacare.26.5.1553. Diabetes Care. 2003. PMID: 12716821 Review.
-
The American Diabetes Association and World Health Organization classifications for diabetes: their impact on diabetes prevalence and total and cardiovascular disease mortality in elderly Japanese-American men.Diabetes Care. 2002 Jun;25(6):951-5. doi: 10.2337/diacare.25.6.951. Diabetes Care. 2002. PMID: 12032097
-
Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality.J Clin Endocrinol Metab. 2015 Jun;100(6):2443-8. doi: 10.1210/jc.2015-1748. J Clin Endocrinol Metab. 2015. PMID: 26047073
-
Diabetic autonomic neuropathy.Handb Clin Neurol. 2014;126:63-79. doi: 10.1016/B978-0-444-53480-4.00006-0. Handb Clin Neurol. 2014. PMID: 25410215 Review.
Cited by
-
Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes.Diabetes Care. 2012 Apr;35(4):809-16. doi: 10.2337/dc11-1652. Epub 2012 Feb 22. Diabetes Care. 2012. PMID: 22357183 Free PMC article.
-
Age and Disease Duration Independent Cardiac Autonomic Neuropathy in Patients with Diabetic Foot Complications: Case-Control Study.Indian J Endocrinol Metab. 2022 Jul-Aug;26(4):362-371. doi: 10.4103/ijem.ijem_99_22. Epub 2022 Sep 20. Indian J Endocrinol Metab. 2022. PMID: 36185960 Free PMC article.
-
Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link?Diabetologia. 2004 Sep;47(9):1488-92. doi: 10.1007/s00125-004-1477-5. Epub 2004 Aug 21. Diabetologia. 2004. PMID: 15322748 Review.
-
A cardiac risk score based on sudomotor function to evaluate cardiovascular autonomic neuropathy in asymptomatic Chinese patients with diabetes mellitus.PLoS One. 2018 Oct 3;13(10):e0204804. doi: 10.1371/journal.pone.0204804. eCollection 2018. PLoS One. 2018. PMID: 30281621 Free PMC article.
-
Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel-group study.Endocrinol Diabetes Metab. 2019 Feb 6;2(2):e00058. doi: 10.1002/edm2.58. eCollection 2019 Apr. Endocrinol Diabetes Metab. 2019. PMID: 31008366 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical